RxDoctor Payments Data

Sean McMahon, MD

Cardiovascular Disease · Hartford, CTNPI 1295050169

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Lantheus Medical Imaging, Inc. at 41.4% of the total. Reporting peaked in 2019 at $8,482 and has fallen 70.4% since, to $2,508 in 2025. Among cardiovascular disease clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,087in general payments, 2019–2025

Across 205 payments — averaging $112.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lantheus Medical Imaging, Inc.$10K
  • Medtronic$6K
  • Abbott$4K
  • Pfizer$2K
  • E.r. Squibb & Sons, L.L.C.$471
  • Edwards Lifesciences$406
  • plus $753 from 13 others

What the payments were for

  • Speaking & faculty fees$9,91943%
  • Travel & lodging$7,01930%
  • Food & beverage$6,14827%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,087 in reported general payments places this provider in the 90th percentile of 415 cardiovascular disease providers in Connecticut.

See all cardiovascular disease providers in Connecticut

Medicare billing

Part B allowed, 2024
$51,320
Medicare patients
553
Services billed
840

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →